Literature DB >> 3310414

[In vivo degradation of immune complexes in the kidney by orally administered enzymes].

C Steffen1, J Menzel.   

Abstract

Preformed immune complexes were deposited in kidney glomeruli of rabbits after i.v. injection. In vivo disintegration of these complexes by orally administered enzymes was investigated. 3 rabbits were given labelled trypsin and papain and the radioactivity and enzyme activity determined in the blood. The radioactive fraction showed an active enzyme concentration of 3-5 mg%. 13 experimental rabbits and 3 control animals received three i.v. injections of 5 ml preformed soluble immune complexes at 12-hour intervals. 24 hours after the last injection the experimental animals were fed 1600 mg enzyme mixture. All animals were sacrificed 4 hours later and the glomeruli of the kidney were investigated by immunofluorescence. All control animals showed large amounts of immune complexes in the glomeruli. Experimental animals, which had all received oral enzymes showed no immune complexes any more, or only residual immune complexes in some glomeruli. This observation pointed to in vivo disintegration of immune complexes by orally-administered enzymes as providing the basis for the treatment of immune complex diseases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310414

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  3 in total

1.  Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.

Authors:  Michael E Lamm; Steven N Emancipator; Janet K Robinson; Michifumi Yamashita; Hisashi Fujioka; Jiazhou Qiu; Andrew G Plaut
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

2.  Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.

Authors:  L Gesualdo; S Ricanati; M O Hassan; S N Emancipator; M E Lamm
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Targeted enzyme therapy of experimental glomerulonephritis in rats.

Authors:  R B White; L Lowrie; J E Stork; S S Iskandar; M E Lamm; S N Emancipator
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.